News ArchivesRead News
Tumours found in rats given stem cells during Parkinson’s study
Thursday October 26, 2006
October 23, 2006 (CBC News) - A potential leap in the treatment of Parkinson’s disease has been tempered with a setback as rats injected with embryonic stem cells were essentially cured of Parkinson’s-like symptoms, but soon developed brain tumours.
When researchers at the University of Rochester transplanted human embryonic stem (HES) cells into the rats, "the implants yielded a significant, substantial and long-lasting restitution of motor function," according to a study published Monday in the online journal of Nature Medicine.
But after 10 weeks into the trial, the scientists discovered the tumours had begun to grow in every rat.
The findings are considered a blow to plans to use HES cells to grow tissues for human transplant.
Stem cells can be thought of as blank slates or cells that have yet to become specialized. They have the ability to become any type of cell to form skin, bones, organs or other body parts.
In particular, researchers have seen the potential for HES cell therapy in curing Parkinson’s because the disease requires only a single cell type that produces dopamine. Dopamine is a neurotransmitter that carries signals between neurons (brain cells).
The brain cells containing dopamine become injured or die in a Parkinson’s patient, which often leads to the person being unable to control physical movements, or they suffer from tremors.
Canada and several other countries have approved strict laws that limit research on stem cells from human embryos.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright